Отсканированное...

9

Transcript of Отсканированное...

Page 1: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 2: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 3: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 4: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 5: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 6: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 7: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 8: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM
Page 9: Отсканированное изображениеnevesk.ru/sites/default/files/kcfinder/files/-11A2...cereBon opraHl.13a1.1HH Ha crpowreT1bCTB0 noAC-raHLIHñ corJ1acHO I K MCTOAHHeCKMM

Bleeding Management in the NOAC era

Bleeding Management in the NOAC era

Non-vitamin K Antagonist Oral Anticoagulant (NOAC) Guidelines

Non-vitamin K Antagonist Oral Anticoagulant (NOAC) Guidelines

STROKE AND ATRIAL FIBRILLATION AND THE ROLE OF THE NOAC

STROKE AND ATRIAL FIBRILLATION AND THE ROLE OF THE NOAC

The Definitive NOAC Pinout

The Definitive NOAC Pinout

IPA. External Audit Internal Audit Audit Committees Governance Framework NOAC.

IPA. External Audit Internal Audit Audit Committees Governance Framework NOAC.

NOAC use - brief handout

NOAC use - brief handout

Updates in NOAC Reversal, What Have We Learned? · NOAC reversal agents. B. Andexanet alfa is recommended for the reversal of rivaroxaban and apixaban and idarucizumab for dabigatran

Updates in NOAC Reversal, What Have We Learned? · NOAC reversal agents. B. Andexanet alfa is recommended for the reversal of rivaroxaban and apixaban and idarucizumab for dabigatran

NOAC for Structural Heart Disease: Update

NOAC for Structural Heart Disease: Update

11A2 Primeras Sociedades Recolectoras

11A2 Primeras Sociedades Recolectoras

NOAC GUIDELINES - Clinical Excellence Commission · noac guidelines non-vitamin k antagonist oral anticoagulant updated july 2017

NOAC GUIDELINES - Clinical Excellence Commission · noac guidelines non-vitamin k antagonist oral anticoagulant updated july 2017

Setting up the NOAC Service & Taking it to Primary …...Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015

Setting up the NOAC Service & Taking it to Primary …...Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015

Fibrilacija atrija terapija varfarinom i NOAC-ima · 2020. 4. 17. · Fibrilacija atrija – terapija varfarinom i NOAC-ima Dr.sc. Jasna Vučak, spec.obiteljske medicine Dr. Marijana

Fibrilacija atrija terapija varfarinom i NOAC-ima · 2020. 4. 17. · Fibrilacija atrija – terapija varfarinom i NOAC-ima Dr.sc. Jasna Vučak, spec.obiteljske medicine Dr. Marijana

Updatein2015:’Novel’Oral’Anticoagulant’(NOAC…multibriefs.com/briefs/cts/noca.pdf · Updatein2015:’Novel’Oral’Anticoagulant’(NOAC)’Drugs’for’Treatment’of’Venous’’

Updatein2015:’Novel’Oral’Anticoagulant’(NOAC…multibriefs.com/briefs/cts/noca.pdf · Updatein2015:’Novel’Oral’Anticoagulant’(NOAC)’Drugs’for’Treatment’of’Venous’’

PRADAXA— ONLY NOAC A SPECIFIC REVERSAL AGENT

PRADAXA— ONLY NOAC A SPECIFIC REVERSAL AGENT

Observations from Novel Oral Anticoagulant (NOAC) Trials ...Observations from Novel Oral Anticoagulant (NOAC) Trials for Stroke Prevention in Atrial Fibrillation (SPAF) CSRC NOAC Dosing

Observations from Novel Oral Anticoagulant (NOAC) Trials ...Observations from Novel Oral Anticoagulant (NOAC) Trials for Stroke Prevention in Atrial Fibrillation (SPAF) CSRC NOAC Dosing

DIA TIPICO 11A2

DIA TIPICO 11A2

2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: …ekjm.org/upload/kjm-2019-94-1-40.pdf2018 대한부정맥학회 심방세동 환자에서 noac 사용 지침:

2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: …ekjm.org/upload/kjm-2019-94-1-40.pdf2018 대한부정맥학회 심방세동 환자에서 noac 사용 지침:

Dimitrios A. Stakos - Livemedia.gr...Acute coronary syndrome on NOAC →ANGIO / PCI UA/ non–STEMI (In the absence of electrical or hemodynamic instability) :: Discontinue NOAC -

Dimitrios A. Stakos - Livemedia.gr...Acute coronary syndrome on NOAC →ANGIO / PCI UA/ non–STEMI (In the absence of electrical or hemodynamic instability) :: Discontinue NOAC -

WHICH NOAC TO USE FOR VTE

WHICH NOAC TO USE FOR VTE

2015 NOAC “Dared to Do” - files.ctctcdn.comfiles.ctctcdn.com/60d98ed5001/8d870460-8668-48c8-a1f7-2b8ee1d2a60b.pdf · 2015 NOAC “Dared to Do” What No Other NOAC Has ... Well,

2015 NOAC “Dared to Do” - files.ctctcdn.comfiles.ctctcdn.com/60d98ed5001/8d870460-8668-48c8-a1f7-2b8ee1d2a60b.pdf · 2015 NOAC “Dared to Do” What No Other NOAC Has ... Well,